Eisai

Eisai Co., Ltd. is a renowned pharmaceutical company that has made significant contributions to the healthcare industry. Founded in Japan in 1941 by Dr. Shinjiro Ehara, the company takes its name from a Buddhist term meaning "medicine for the benefit of humanity." Throughout its history, Eisai has embodied this philosophy, dedicating itself to improving human health and quality of life.

One of Eisai's key areas of focus is neurology, particularly Alzheimer's disease and epilepsy. The company has developed innovative treatments for these challenging conditions, providing hope and relief to countless patients and their families. Eisai's commitment to research and development has resulted in the discovery of groundbreaking medications that have garnered global recognition.

Beyond neurology, Eisai also engages in the development of treatments for various other diseases, including cancer, gastrointestinal disorders, and metabolic disorders. The company's extensive portfolio of pharmaceutical products covers a broad spectrum of therapeutic areas, catering to diverse medical needs worldwide.

Furthermore, Eisai's commitment to sustainability and environmental responsibility is evident in its efforts to reduce its carbon footprint and contribute to a greener future. The company aims to create a society where people can live in harmony with nature while enjoying good health.

Founded: 1941

Founder: Dr. Shinjiro Ehara

Headquarters: Tokyo, Japan

Website: https://www.eisai.com/